【problems with 2005 buick lesabre】Best & Worst Performing Stocks in Coronavirus Outbreak
Theproblems with 2005 buick lesabre coronavirus outbreak and its subsequent impact on corporate profit margins and the global economy continue to dominate the headlines. U.S. stocks endured their worst weekly slide on Feb 28 since October 2008. In fact, all the major indexes closed in the correction territory last Thursday, and several well-known companies like Nike, United Airlines and Mastercard issued earnings and revenue warnings.
Goldman Sachs’ chief global equity strategist, Peter Oppenheimer, added that “in the nearer term…we believe the greater risk is that the impact of the coronavirus on earnings may well be underestimated in current stock prices, suggesting that the risks of a correction are high.”
But U.S. stocks did make a roaring comeback on Mar 2 after investors started to believe that central banks around the world, including the Fed, would take actions to put a check on the steep losses. Most of them are widely expecting a coordinated global effort to trim rates to stimulate the economy.
Australian central bank’s governor in the meantime acknowledged that the coronavirus outbreak does have a “significant effect” on the country’s economy and any move to ease monetary policy will certainly “provide additional support to employment and economic activity.”
However, let’s admit we can not completely write off the adverse impact of the outbreak, and the U.S. stock market will continue to gyrate in the days to come. After all, the disease continues to spread. The virus has reached countries beyond China, including the United States, Italy, Germany, Iran and South Korea.
Nonetheless, these stocks are the big winners and losers since the coronavirus outbreak stalled the U.S. bull market —
Stocks That Defied the Coronavirus Pandemic
Co-Diagnostics, Inc. CODX, Moderna, Inc. MRNA, Regeneron Pharmaceuticals, Inc. REGN and Netflix, Inc. NFLX are some of the prominent names that have soared 1889.5%, 33%, 23.8% and 17.8%, respectively, so far this year amid the coronavirus rout. Take a look —
Molecular diagnostics company Co-Diagnostics has introduced an easier-to-use molecular diagnostic test known as the Logix Smart Coronavirus COVID-19 test. And the company has received a CE mark approval from the European Union to make this test commercially available.
With the outbreak spreading rapidly, the need for molecular diagnostic tests will increase, and in turn, boost Co-Diagnostics’ revenues. The company currently has a Zacks Rank #2 (Buy). The Zacks Consensus Estimate for its current-year earnings has moved up 66.7% over the past 60 days. What’s more, the company’s expected earnings growth rate for the next quarter is 44.4%. You can see
the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Story continues
Clinical stage biotechnology company, Moderna has manufactured a new vaccine for coronavirus treatment. Unlike DNA-based treatments, Moderna focuses on developing mRNA treatments, which should help in treating the virus better. DNA-based treatments generally require the nucleus of the cell but mRNA can be found across the cell which makes it easily accessible.
Moderna, by the way, has been pretty impressive. After getting to know the virus’ genetic composition, it took the company less than two months to develop the vaccine. Moderna currently has a Zacks Rank #2. The Zacks Consensus Estimate for its current-year earnings has moved up 6.2% over the past 60 days. The company’s expected earnings growth rate for the current and next quarter is 7.5% and 9.8%, respectively.
Based on Ebola knowledge, Regeneron Pharmaceuticals is making a vaccine to tackle COVID-19. Regeneron’s initiative to prepare such a potent weapon helped its shares increase leaps and bounds this year especially when compared to the mere 2.5% it brought in for the last 12 months. By the way, the company is doing well in itself. Its fourth-quarter results were impressive, wherein both sales and earnings beat estimates on label expansion of Eylea and Dupixent.
Regeneron currently possesses a Zacks Rank #1. The Zacks Consensus Estimate for its current-year earnings has moved up 6.4% over the past 60 days. The company’s expected earnings growth rate for the current and next quarter is 35.5% and 15.1%, respectively.
Apart from biotech stocks, Netflix’s shares have gained because the company has an established business models and is fundamentally strong enough to provide hedge against any downfall. Firstly, it primarily provides streaming services, so any lockdown in response to the coronavirus outbreak won’t have any impact on its subscriber growth. In fact, Netflix added 8.8 million subscribers internationally last quarter, surpassing analysts’ expectations by more than a million.
Netflix’s subscriber growth was mostly driven by content strength, focus on originals across various genres and languages, rapid international expansion and partnerships with telcos. Meanwhile, Netflix entered this year’s Oscars with 24 nominations, and walked away with two wins. Such wins will certainly help Netflix lure and retain subscribers in the face of challenges from rival services like Disney+ and Apple TV+.
Netflix currently has a Zacks Rank #2. The Zacks Consensus Estimate for its current-year earnings has moved 10.6% north over the past 60 days. The company’s expected earnings growth rate for the current quarter and year is a promising 119.7% and 46.7%, respectively (read more: Coronavirus Fears Holding You Back? 3 Smart Ways to Invest).
Not So Lucky Ones
With so many people affected across the globe by the spread of the contagious disease, travel-related stocks were hit hard. Cruise operators were among the worst hit. Shares of Norwegian Cruise Line Holdings Ltd. NCLH have tanked 39.1% on a year-to-date basis. After all, the company has generated 2% of its revenues from China over the last 12 months. Airline stocks were also collectively affected, and most prominently American Airlines Group Inc.’s AAL shares have slipped 34.2% so far this year.
Coming back to revenue exposure, energy giant Chevron Corporation CVX have seen its shares slide 19.8% so far this year. This is because Chevron’s revenue exposure to China is about 27%. The Boeing Company BA also took a beating. Boeing’s shares fell 11.3% on a year-to-date basis, as the manufacturer of commercial jetliner has a slightly more than 13% revenue exposure to China, according to FactSet.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.
See these 7 breakthrough stocks now>>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days.
Click to get this free report
The Boeing Company (BA) : Free Stock Analysis Report
Regeneron Pharmaceuticals, Inc. (REGN) : Free Stock Analysis Report
Chevron Corporation (CVX) : Free Stock Analysis Report
Moderna, Inc. (MRNA) : Free Stock Analysis Report
Netflix, Inc. (NFLX) : Free Stock Analysis Report
American Airlines Group Inc. (AAL) : Free Stock Analysis Report
Norwegian Cruise Line Holdings Ltd. (NCLH) : Free Stock Analysis Report
Co-Diagnostics, Inc. (CODX) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
View comments
(责任编辑:Encyclopedia)
- How Much is Wisdom Education International Holdings Company Limited's (HKG:6068) CEO Getting Paid?
- Unibail-Rodamco-Westfield (“URW”) announces tender offer results
- Russia's Ozon wants dual listing in Moscow and U.S. -sources
- Why the Earnings Surprise Streak Could Continue for Dick's (DKS)
- Company News for Mar 10, 2020
- What Kind Of Investors Own Most Of IBI Group Inc. (TSE:IBG)?
- EXPLAINER-Why is Israel holding its third election in a year?
- HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Crown Castle (CCI) Investors Who Have Suffered Losses to Contact its Attorneys: Securities Fraud Case Filed
- Wall Street Week Ahead: Bond investors look for Fed to justify steepening yield curve
- Transformative Mega Trends Reshaping the Indian ICT Landscape
- FINAL DEADLINE TODAY: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against HDFC Bank Limited and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
- Deutsche (DB) Ratings Affirmed by Moody's, Outlook Upgraded
- Unum (UNM) Q1 Earnings and Revenues Lag Estimates
-
ROYAL DUTCH SHELL PLC THIRD QUARTER 2020 EURO AND GBP EQUIVALENT DIVIDEND PAYMENTS
The Hague, December 3, 2020 - The Board of Royal Dutch Shell plc (“RDS”) today announced the pounds ...[详细] -
Notification of Major Holdings
TR-1: Standard form for notification of major holdingsNOTIFICATION OF MAJOR HOLDINGS(to be sent to t ...[详细] -
Global Hospital Beds Market Report 2020: Market to Reach $5.2 Billion by 2027
Dublin, Dec. 04, 2020 (GLOBE NEWSWIRE) -- The"Hospital Beds - Global Market Trajectory & Analytics"r ...[详细] -
With EPS Growth And More, Anchorstone Holdings (HKG:1592) Is Interesting
For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a ...[详细] -
High-Yield ETF Rout Widens Gap With Benchmarks
(Bloomberg Opinion) -- Ever since the introduction of exchange-traded funds tracking the riskiest bo ...[详细] -
Notification of Major Holdings
TR-1: Standard form for notification of major holdingsNOTIFICATION OF MAJOR HOLDINGS(to be sent to t ...[详细] -
Today we'll take a closer look at Allegiance Bancshares, Inc. (NASDAQ:ABTX) from a dividend investor ...[详细]
-
Cheap oil prices likely to reduce inflationary pressures in India: government adviser
By Manoj KumarNEW DELHI (Reuters) - A fall in global crude oil prices will likely reduce inflationar ...[详细] -
People are getting this unexpected stimulus check. Should you keep it?
Payments from the$2.2 trillion coronavirus relief packagehave gone out to many people across the Uni ...[详细] -
GLOBAL MARKETS-Asian shares go flat as China data disappoints
* Asian stock markets :https://tmsnrt.rs/2zpUAr4* Caixin/Markit PMI falls to three-year low of 48.3* ...[详细]
Hermès Opens Significantly Larger Shop in Las Vegas
Is It Smart To Buy Garmin Ltd. (NASDAQ:GRMN) Before It Goes Ex-Dividend?
- JPMorgan (JPM) Plans for 20% Rise in 2020-end Trading Bonus
- J.C. Penney announces locations of 154 stores closing across the US
- INVESTOR ALERT: Kirby McInerney LLP Continues Investigation of Shareholder Claims Against Hallmark Financial Services Inc.
- Baker Hughes Snaps Up Compact Carbon Capture For Energy Transition Path
- Unionized employees strike at Tasiast mine
- What Does BNP Paribas Know That the Markets Don't?
- iRhythm Technologies, Inc. Just Reported Full-Year Earnings: Have Analysts Changed Their Mind On The Stock?